Atlas Trials

Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Clinical trial NCT02111941 · COMPLETED

Trial details

NCT number
NCT02111941
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Mucinous NeoplasmFallopian Tube Serous NeoplasmFallopian Tube Transitional Cell CarcinomaOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Mucinous CystadenocarcinomaOvarian Seromucinous CarcinomaOvarian Serous CystadenocarcinomaOvarian Transitional Cell CarcinomaPrimary Peritoneal Serous Adenocarcinoma
Start date
2014-04-14
Primary completion
2021-07-27
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.